New Microneedle-Based Injection Device From NanoPass  
8/14/2009 7:24:01 AM

Bookmark and Share

News-Medical -- Following the World Health Organization (WHO) declaration of a swine flu pandemic, NanoPass Technologies Ltd. (NanoPass) announced today that it has successfully developed a microneedle-based injection device that could dramatically enhance both the effectiveness and supply of pandemic flu vaccines.